1. Воробьев А.И. Руководство по гематологии. T. 2. М.: Ньюдиамед, 2003. 202–205 p.
2. К.Д. Краснопольская. Наследственные болезни обмена веществ. 2005. 20–22 p.
3. Horowitz M. et al. The human glucocerebrosidase gene and pseudogene: Structure and evolution // Genomics. 1989.
4. Futerman A.H., Zimran A. Gaucher disease // Gaucher Disease. 2006.
5. Pastores G.M. et al. Therapeutic goals in the treatment of Gaucher disease // Semin. Hematol. 2004.
6. Boven L.A. et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages // Am. J. Clin. Pathol. 2004.
7. Р.В. Пономарев. Динамика лабораторных показателей, отражающих активность макрофагальной системы, у пациентов с болезнью Гоше на фоне патогенетической терапии. Дис. канд. мед. наук. 2020. 105 p.
8. Movsisyan G.B. et al. Demographic, Clinical and Genetic Characteristics of Child Gaucher Disease Patients in Russia: Pediatric Register Data // Pediatr. Pharmacol. 2016.
9. Mikosch P. Editorial: Gaucher disease // Wiener Medizinische Wochenschrift. 2010.
10. Stone D.L. et al. Type 2 Gaucher disease: The collodion baby phenotype revisited // Arch. Dis. Child. Fetal Neonatal Ed. 2000.
11. Gupta N. et al. Type 2 Gaucher disease: Phenotypic variation and genotypic heterogeneity // Blood Cells, Molecules, and Diseases. 2011.
12. Huang W.J., Zhang X., Chen W.W. Gaucher disease: A lysosomal neurodegenerative disorder // Eur. Rev. Med. Pharmacol. Sci. 2015.
13. Weiss K. et al. The clinical management of type 2 Gaucher disease // Molecular Genetics and Metabolism. 2015.
14. Goker-Alpan O. et al. Phenotypic continuum in neuronopathic Gaucher disease: An intermediate phenotype between type 2 and type 3 // J. Pediatr. 2003.
15. Nagral A. Gaucher disease // Journal of Clinical and Experimental Hepatology. 2014.
16. Rosenbloom B.E., Weinreb N.J. Gaucher disease: A comprehensive review // Crit. Rev. Oncog. 2013.
17. Weinthal J.A. Prognosis of patients with Gaucher disease // Clin. Adv. Hematol. Oncol. 2012.
18. Tylki-Szymańska A. et al. Neuronopathic Gaucher disease: Demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry // J. Inherit. Metab. Dis. 2010.
19. Mankin H.J., Rosenthal D.I., Xavier R. Current concepts review gaucher disease: New approaches to an ancient disease: New approaches to an ancient disease // Journal of Bone and Joint Surgery - Series A. 2001.
20. Е.А. Лукина. Болезнь Гоше. М.: Литерра, 2011. 54 p.
21. Zimran A. et al. Gaucher disease: Clinical, laboratory, radiologic, and genetic features of 53 patients // Med. (United States). 1992.
22. Stein P. et al. Hyperferritinemia and iron overload in type 1 Gaucher disease // Am. J. Hematol. 2010. Vol. 85, № 7. P. 472–476.
23. Wenstrup R.J. et al. Skeletal aspects of Gaucher disease: A review // British Journal of Radiology. 2002.
24. Лукина К.А. Клинические и молекулярные факторы, ассоциированные с поражением костно-суставной системы при болезни Гоше I типа: дис. канд. мед. наук. 2013. 142 p.
25. Cox T.M., Schofield J.P. Gaucher’s disease: Clinical features and natural history // Baillieres. Clin. Haematol. 1997.
26. Erikson A. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment. // Acta Paediatr. Scand. Suppl. 1986.
27. Grabowski G.A., Zimran A., Ida H. Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry // American Journal of Hematology. 2015.
28. Mariani S. et al. Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis // Acta Haematol. 2018.
29. Zimran A. How I treat Gaucher disease // Blood. 2011.
30. Santoro D., Rosenbloom B.E., Cohen A.H. Gaucher disease with nephrotic syndrome: response to enzyme replacement therapy. // Am. J. Kidney Dis. 2002.
31. Becker-Cohen R. et al. A comprehensive assessment of renal function in patients with Gaucher disease // Am. J. Kidney Dis. 2005.
32. Morimura Y. et al. Gaucher’s disease, type I (adult type), with massive involvement of the kidneys and lungs // Virchows Arch. 1994.
33. Chander P.N., Nurse H.M., Pirani C.L. Renal involvement in adult Gaucher’s disease after splenectomy // Arch. Pathol. Lab. Med. 1979.
34. Delpre G., Stark P., Niv Y. B12 deficiency: Not an uncommon genetic-related disorder [7] // British Journal of Haematology. 2002.
35. Regenboog M. et al. Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications // Blood Rev. Elsevier Ltd, 2016. Vol. 30, № 6. P. 431–437.
36. Deegan P.B. et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease // Blood Cells, Mol. Dis. 2005.
37. Stein P. et al. Hyperferritinemia and iron overload in type 1 Gaucher disease // Am. J. Hematol. 2010.
38. Biegstraaten M. et al. Peripheral neuropathy in adult type 1 Gaucher disease: A 2-year prospective observational study // Brain. 2010.
39. Deghady A. et al. Coagulation abnormalities in type 1 Gaucher disease in children // Pediatr. Hematol. Oncol. 2006.
40. Öztürk G. et al. Coagulopathy in Gaucher disease. // Indian journal of pediatrics. 1998.
41. Kurokawa T., Ohkohchi N. Platelets in liver disease, cancer and regeneration // World J. Gastroenterol. 2017.
42. Arends M. et al. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature // Br. J. Haematol. 2013.
43. Ivanova M. et al. Gaucheromas: When macrophages promote tumor formation and dissemination // Blood Cells, Mol. Dis. 2018.
44. Baldini M. et al. Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density // Blood Cells, Mol. Dis. 2018.
45. Andrade-Campos M. et al. The utility of magnetic resonance imaging for bone involvement in Gaucher disease. Assessing more than bone crises // Blood Cells, Mol. Dis. 2018.